Our study demonstrates that Aurora-A is a novel kinase in regulating Maf1 function and targeting Aurora-A may be a promising strategy in cancer therapy, particularly for HCC patients with higher expression levels of Maf1 and Aurora-A. The gene discussed is MAF1; the disease is cancer.